BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 113.51 USD 0.38% Market Closed
Market Cap: 27.4B USD
Have any thoughts about
BioNTech SE?
Write Note

Balance Sheet

Balance Sheet Decomposition
BioNTech SE

Current Assets 18.5B
Cash & Short-Term Investments 16.7B
Receivables 1.2B
Other Current Assets 578.9m
Non-Current Assets 3.9B
Long-Term Investments 1.3B
PP&E 1.2B
Intangibles 1.2B
Other Non-Current Assets 175.5m
Current Liabilities 2.5B
Accounts Payable 762.6m
Other Current Liabilities 1.8B
Non-Current Liabilities 764.2m
Long-Term Debt 206.3m
Other Non-Current Liabilities 557.9m

Balance Sheet
BioNTech SE

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
172
411
519
1 210
1 693
13 875
11 664
Cash
172
411
519
1 210
1 693
13 875
11 664
Short-Term Investments
0
0
2
137
382
189
4 885
Total Receivables
9
28
20
171
12 382
7 146
2 340
Accounts Receivables
5
19
12
165
12 382
7 146
2 161
Other Receivables
4
9
8
6
0
0
179
Inventory
4
6
12
64
503
440
358
Other Current Assets
5
3
7
85
113
272
281
Total Current Assets
190
449
560
1 667
15 072
21 922
19 527
PP&E Net
102
116
148
326
520
821
972
PP&E Gross
102
116
148
326
520
821
972
Accumulated Depreciation
28
37
49
58
74
116
212
Intangible Assets
83
88
86
110
145
159
804
Goodwill
1
1
3
54
58
61
363
Long-Term Investments
0
0
0
0
21
80
1 176
Other Long-Term Assets
0
0
0
162
14
236
165
Other Assets
1
1
3
54
58
61
363
Total Assets
375
N/A
653
+74%
798
+22%
2 319
+191%
15 831
+583%
23 279
+47%
23 006
-1%
Liabilities
Accounts Payable
53
42
20
102
160
204
354
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
8
3
6
130
36
28
Other Current Liabilities
104
76
114
498
3 192
2 711
1 688
Total Current Liabilities
159
126
138
606
3 482
2 951
2 071
Long-Term Debt
0
6
69
231
172
176
191
Deferred Income Tax
0
0
0
0
67
6
40
Minority Interest
1
1
0
0
0
0
0
Other Liabilities
264
254
97
109
217
91
459
Total Liabilities
424
N/A
387
-9%
304
-21%
947
+212%
3 937
+316%
3 224
-18%
2 760
-14%
Equity
Common Stock
167
193
232
246
246
249
249
Retained Earnings
216
73
267
1 130
11 651
19 812
20 008
Treasury Stock
0
0
6
5
4
5
11
Total Equity
49
N/A
266
N/A
493
+85%
1 372
+178%
11 894
+767%
20 056
+69%
20 246
+1%
Total Liabilities & Equity
375
N/A
653
+74%
798
+22%
2 319
+191%
15 831
+583%
23 279
+47%
23 006
-1%
Shares Outstanding
Common Shares Outstanding
226
226
227
242
243
243
238

See Also

Discover More